gatifloxacin has been researched along with E coli Infections in 5 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gatifloxacin therapy was more rapidly bactericidal than cefotaxime but similar to meropenem therapy (bacterial killing rates at 5 h, 0." | 1.30 | Efficacy of gatifloxacin in experimental Escherichia coli meningitis. ( Friedland, IR; Ghaffar, F; Jafri, HS; Lutsar, I; McCracken, GH; Ng, W; Wubbel, L, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanheira, M | 1 |
| Pereira, AS | 1 |
| Nicoletti, AG | 1 |
| Pignatari, AC | 1 |
| Barth, AL | 1 |
| Gales, AC | 1 |
| Yamane, K | 1 |
| Wachino, J | 1 |
| Suzuki, S | 1 |
| Kimura, K | 1 |
| Shibata, N | 1 |
| Kato, H | 1 |
| Shibayama, K | 1 |
| Konda, T | 1 |
| Arakawa, Y | 1 |
| Cattoir, V | 1 |
| Poirel, L | 1 |
| Nordmann, P | 1 |
| Li, C | 1 |
| Liu, JC | 1 |
| Li, YR | 1 |
| Gou, C | 1 |
| Zhang, ML | 1 |
| Liu, HY | 1 |
| Li, XZ | 1 |
| Zheng, CJ | 1 |
| Piao, HR | 1 |
| Lutsar, I | 1 |
| Friedland, IR | 1 |
| Jafri, HS | 1 |
| Wubbel, L | 1 |
| Ng, W | 1 |
| Ghaffar, F | 1 |
| McCracken, GH | 1 |
5 other studies available for gatifloxacin and E coli Infections
| Article | Year |
|---|---|
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Con | 2007 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Esch | 2008 |
Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety.
Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Escherichia coli; Escherichia coli Infections; | 2015 |
Efficacy of gatifloxacin in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Infective Agents; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gat | 1999 |